About the Company
Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Niagen Bioscience, Inc.
Niagen Bioscience Inc (NAGE) Q2 2025: Everything You Need To Know Ahead Of Earnings
Niagen Bioscience Inc (NASDAQ:NAGE) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 ...
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
As you might know, Niagen Bioscience, Inc. (NASDAQ:NAGE) just kicked off its latest quarterly results with some very strong numbers. It was overall a positive result, with revenues beating ...
Niagen Bioscience, Inc. Reports First Quarter 2025 ... - Morningstar
Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook Total net sales of $30.5 million, up $8.3 million or 38% year-over-year, gross margin of 63.4%, net ...
What 4 Analyst Ratings Have To Say About Niagen Bioscience
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative ...
Breaking Down Niagen Bioscience: 4 Analysts Share Their Views
Analysts have recently evaluated Niagen Bioscience and provided 12-month price targets. The average target is $16.0, accompanied by a high estimate of $23.00 and a low estimate of $12.00. This current ...
Niagen Bioscience, Inc. (NAGE) Q1 2025 Earnings Call Transcript
Call Start: 16:30 January 1, 0000 5:16 PM ETNiagen Bioscience, Inc.Q1 2025 - Earnings Conference CallMay 7, 2025, 04:30 PM ETCompany ParticipantsWesley Yu - ...
Niagen Bioscience, Inc. Rings the Nasdaq Stock Market Closing Bell
Niagen Bioscience, Inc. (Nasdaq: NAGE), the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research, visits the Nasdaq MarketSite in Times Square celebrating ...
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates
Niagen Bioscience (NAGE) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to break-even earnings per share a year ago. These ...
Niagen Bioscience to Participate in the BIO 2025 International ...
Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced ...
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference
Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that ...
Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results ...
The Company announced its corporate name change to Niagen Bioscience, Inc. and commenced trading under the new Nasdaq ticker “NAGE,” effective March 19, 2025.
Similar Companies
Loading the latest forecasts...